pobilukast has been researched along with sk&f s-106203 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckardt, RD; Gleason, JG; Hay, DW; Muccitelli, RM; Novak, LS; Osborn, RR; Sarau, HM; Saverino, CM; Vickery-Clark, LM; Yodis, LA | 1 |
1 other study(ies) available for pobilukast and sk&f s-106203
| Article | Year |
|---|---|
Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig.
Topics: Animals; Dicarboxylic Acids; Guinea Pigs; In Vitro Techniques; Lung; Male; Muscle Contraction; Muscle, Smooth; Phosphodiesterase Inhibitors; Receptors, Immunologic; Receptors, Leukotriene; SRS-A; Trachea | 1991 |